PND3 Improvements in Migraine-specific Quality of Life Questionnaire (MSQ) Domain Scores with Fremanezumab and Galcanezumab in Patients with Multiple Prior Migraine Preventive Treatment Failures: A Network Meta-analysis
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.787
https://www.valueinhealthjournal.com/article/S1098-3015(21)01004-4/fulltext
Title :
PND3 Improvements in Migraine-specific Quality of Life Questionnaire (MSQ) Domain Scores with Fremanezumab and Galcanezumab in Patients with Multiple Prior Migraine Preventive Treatment Failures: A Network Meta-analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01004-4&doi=10.1016/j.jval.2021.04.787
First page :
Section Title :
Open access? :
No
Section Order :
10290